SUNREGEN
SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases. They focus on innovative treatments for patients suffering from neurological, neuromuscular and ophthalmic diseases. Their first product candidates in development target primary optical atrophy. They are further evaluating them for use in serious neurological / neuromuscular diseases such as ALS, Huntington's, Alzheimer’s and Parkinson’s disease. Their team is composed of passionate... and innovative founders and experts who have solid track records in drug development and clinical research in multinational pharmaceutical companies or management experience in international technology enterprises. Their determination in bringing life-changing treatments to patients encompasses everything they do.
SUNREGEN
Social Links:
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Allschwil, Basel-Landschaft, Switzerland
Country:
Switzerland
Website Url:
http://www.sunregen.ch
Total Employee:
1+
Status:
Active
Contact:
+41 (0)76 480 56 28
Email Addresses:
[email protected]
Total Funding:
71.43 K EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Mobile Non Scaleable Content Apache Microsoft Exchange Online Office 365 Mail YouTube GoDaddy DNS GoDaddy
Similar Organizations
Arvelle Therapeutics
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
DegenRx
Biopharmaceutical company developing novel therapeutic solutions to treat neurodegenerative diseases
Hunter-Fleming Ltd
Hunter-Fleming Ltd is a biopharmaceutical company developing new medicines to treat neurodegenerative and inflammatory disorders.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
GoBeyond
GoBeyond investment in Series A - SunRegen
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - SunRegen
Official Site Inspections
http://www.sunregen.ch
- Host name: 172.67.174.225
- IP address: 172.67.174.225
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SunRegen"
SunRegen Healthcare AG
The typical clinical phenomenon of RP indication is apoptosis of photoreceptor cells, which leads to visual impairment and blindness. SunRegen is developing first-in-class drugs to prevent and …See details»
SunRegen - Crunchbase Company Profile & Funding
Organization. SunRegen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +41 …See details»
SunRegen Healthcare AG - Swiss Biotech
SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases. Products, services, technology SunRegen is focusing on …See details»
SunRegen 2025 Company Profile: Valuation, Funding & Investors
SunRegen General Information Description. Operator of a biopharmaceutical company intended to develop drugs to treat neurodegenerative diseases. The company's services mainly focus …See details»
SunRegen Healthcare AG Overview | SignalHire Company Profile
SunRegen Healthcare AG is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. …See details»
SunRegen Company Profile - Office Locations, Competitors ... - Craft
SunRegen has 5 employees across 2 locations and $83.4 k in total funding,. See insights on SunRegen including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
SunRegen Healthcare AG - VentureRadar
SunRegen Healthcare AG is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases. We focus on innovative treatments for patients suffering …See details»
News of SunRegen
Oct 3, 2017 SunRegen’s pre-RTO capital raise is currently in progress. The next step is to complete a concurrent financing. The use of proceeds of the anticipated financing will be to …See details»
SunRegen Healthcare AG - VentureRadar
SunRegen Healthcare AG is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases. We focus on innovative treatments for patients suffering …See details»
Chief Executive Officer – SunRegen Healthcare AG - LinkedIn
CEO, Founder at SunRegen Healthcare AG · Devoting to a highly honoured business which will make great contributions to the human being! · SunRegen Healthcare AG · Basel · 425 …See details»
SunRegen Healthcare AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SunRegen Healthcare AG of Reinach BL, BASEL-LAND. Get the latest business insights from Dun & …See details»
SunRegen Healthcare AG - Reinach BL, Schweiz - bionity.com
Sunregen.ch +41 61 599 83 42. Teilen. Xing Linkedin Facebook X E-mail Loading... Merken. Merkliste aufrufen; Merken. Start-up. SunRegen Healthcare AG. Robinienweg 51 4153 …See details»
SunRegen Healthcare AG | BusinessParc
Www.sunregen.ch. Mitglied. Alle Filter zurücksetzen. a. Advokatur Rey. Rechtsberatung; Aeroquint. Unternehmens-Dienstleistung; Entwicklung und Vermarktung von …See details»
SunRegen Healthcare AG - startup.ch
SunRegen wins international biotech startup competition (startupticker.ch) 07.11.2018 BIO-Europe® Copenhagen's Startup Slam Winner 2018: SunRegen Healthcare AGSee details»
SunRegen Healthcare wins startup competition - BaseLaunch
Nov 9, 2018 SunRegen Healthcare wins startup competition. By Jérémie Meyer 09.11.2018 September 17th, 2020 Features. No Comments ...See details»
SunRegen - Switzerland Innovation Park Basel Area
SunRegen Healthcare AG is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases. We focus on innovative treatments for patients suffering …See details»
SunRegen Healthcare AG
A Swiss Basel-Area based bio-pharmaceutical company developing novel and neuro-rescuing therapies to treat and reverse retinal and central nerve neurodegenerative diseases.See details»
SunRegen - Products, Competitors, Financials, Employees, …
As announced on August 12, 2024, Verisante entered into a binding Letter of Intent ("LOI") to acquire a 100% interest in SunRegen Healthcare AG ("SunRegen"), a Swiss pharmaceutical …See details»
SunRegen Healthcare to go public via reverse takeover
Aug 20, 2024 SunRegen focusses on the development of neurodegenerative related drugs. Both parties intend to negotiate and enter into a Definitive Share Exchange Agreement prior to …See details»
New at Switzerland Innovation Park Basel Area: SunRegen
The biopharmaceutical company SunRegen Healthcare develops a therapy for neurodegenerative eye diseases like Optic Atrophy. The two co-founders and managers Dr. Yuhong Dong and …See details»